Related Experiment Video
Updated: May 10, 2026

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
Published on: March 2, 2020
Ciprofloxacin Resistance in Enterococcus faecalis Strains Isolated From Male Patients With Complicated Urinary Tract
1Department of Urology, Dankook University College of Medicine, Cheonan, Korea.
Purpose:
Urinary tract infection (UTI) is one of the most prevalent bacterial infections, and fluoroquinolone therapy is a well-known standard regimen for UTI. The prevalence and risk factor analysis of fluoroquinolone resistance in enterococcal UTIs are not well documented. The aim of this study was to evaluate the antimicrobial susceptibility and risk factors for ciprofloxacin resistance in Enterococcus faecalis strains isolated from patients with complicated UTI.
Materials And Methods:
We evaluated 81 E. faecalis strains isolated from 81 male patients at a single teaching hospital over 3 years. The Vitek 2 automatic system was used for antimicrobial susceptibility analysis.
Results:
Antimicrobial resistance rates were rare for ampicillin/sulbactam, imipenem, and vancomycin in E. faecalis. Forty-six percent of the E. faecalis strains were resistant to levofloxacin, 47% were resistant to ciprofloxacin, and 58% were resistant to norfloxacin. E. faecalis strains were highly resistant to erythromycin (92%) and ftetracycline (96%). The risk factor analysis revealed that age intervals, the underlying diseases, catheterization, and the number of admissions did not increase the risk of ciprofloxacin resistance, whereas patients with hospital-acquired infection (odds ratio [OR], 18.15; 95% confidence interval [CI], 3.46 to 95.13; p=0.001), patients who were treated in a urological department (OR, 6.15; 95% CI, 1.5 to 25.41; p=0.012), and patients who were transferred from health care centers (OR, 7.393; 95% CI, 1.32 to 41.22; p=0.023) had an increased risk of ciprofloxacin resistance compared with the matched controls.
Conclusions:
Ciprofloxacin is no longer a recommended therapy for E. faecalis from complicated UTI in men with risk factors. We suggest that ampicillin/sulbactam can be recommended as alternatives for treating ciprofloxacin-resistant E. faecalis strains associated with UTI in Korea.
Insights
Ciprofloxacin resistance is high in Enterococcus faecalis causing complicated urinary tract infections (UTIs) in men. Hospital-acquired infections and urological department treatment increase resistance risk, suggesting alternative therapies like ampicillin/sulbactam.
Area of Science:
- Infectious Diseases
- Urology
- Microbiology
Background:
- Urinary tract infections (UTIs) are common bacterial infections.
- Fluoroquinolones, including ciprofloxacin, are standard UTI treatments.
- Enterococcal UTIs and fluoroquinolone resistance patterns require further investigation.
Purpose of the Study:
- To assess antimicrobial susceptibility of Enterococcus faecalis strains.
- To identify risk factors for ciprofloxacin resistance in complicated UTIs.
- To evaluate E. faecalis isolates from male patients in a Korean teaching hospital.
Main Methods:
- Analysis of 81 E. faecalis strains from male UTI patients over 3 years.
- Antimicrobial susceptibility testing using the Vitek 2 automated system.
- Risk factor analysis comparing resistant and susceptible strains.
Main Results:
- High resistance rates observed for ciprofloxacin (47%), levofloxacin (46%), and norfloxacin (58%).
- E. faecalis showed >90% resistance to erythromycin and tetracycline.
- Hospital-acquired infection, urological department treatment, and transfer from healthcare centers were significant risk factors for ciprofloxacin resistance.
Conclusions:
- Ciprofloxacin is not recommended for complicated UTIs caused by E. faecalis in men with identified risk factors.
- Ampicillin/sulbactam is a potential alternative for treating ciprofloxacin-resistant E. faecalis UTIs in Korea.
- Understanding resistance patterns is crucial for effective UTI management.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Mechanism of Antibiotic Resistance in MRSA
Urine Studies II: Urine Culture and Sensitivity Test
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Development of Antibiotic Resistance
Urinary Tract Infection I: Introduction

